Daré Bioscience, Inc.

Daré Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing products for women's health. The company's revenue is generated through the identification, development, and marketing of therapies in the areas of contraception, fertility, and sexual and vaginal health. Its product portfolio includes XACIATO, a single-dose vaginal gel for the treatment of bacterial vaginosis, Ovaprene, a hormone-free monthly vaginal contraceptive, and Sildenafil Cream for female sexual arousal disorder. Additionally, the company has Phase 1-ready and pre-clinical stage products aimed at addressing various women's health needs, such as hormone therapy, breast cancer-related conditions, and contraception.

Products

• XACIATO

• Ovaprene

• Sildenafil Cream

• DARE-HRT1

• DARE-VVA1

• DARE-FRT1

• DARE-PTB1

• DARE-LARC1

• ADARE-204

• ADARE-214

• DARE-RH1